Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kasofit Q-10 is an oral dietary supplement developed and marketed by Kaiser Drugs Private Limited, an Indian pharmaceutical distributor. The product is a combination of L-carnitine and Coenzyme Q10 (CoQ10), formulated as tablets. Coenzyme Q10 serves as a vital electron carrier in the mitochondrial respiratory chain and acts as a potent lipid-soluble antioxidant, protecting cells from oxidative stress. L-carnitine is an amino acid derivative essential for the transport of long-chain fatty acids into the mitochondrial matrix for energy production via beta-oxidation. Together, these ingredients are intended to provide general nutritional support, enhance mitochondrial health, and provide antioxidant protection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kasofit Q-10.